Follow-The-Filings

Security · featured owners

REGN Regeneron Pharmaceuticals

Health Care COM Equity as of 2026 Q2 among managers we track

  • 6 Owners
  • #234
  • Max 5.0%
  • Master 0.19%
  • $3.2B
  • 3 add 2 reduce

REGN (Regeneron Pharmaceuticals) is held in 6 featured 13F books as of 2026 Q2. Mason Hawkins - Southeastern Asset Management is the largest tracked holder by portfolio weight (5.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 5.0% (Mason Hawkins - Southeastern Asset Management) · not free-float ownership

  1. Mason Hawkins add 5.0%
  2. Harry Burn reduce 2.4%
  3. Dodge & Cox add 1.6%
  4. Michael Krensavage add 1.4%
  5. Murphy Pohlad 0.76%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Dodge & Cox 2026 Q2 1.6% Add +9.3% 4,871,137 $3B history
Mason Hawkins - Southeastern Asset Management 2026 Q2 5.0% Add +16.6% 152,322 $95M history
Harry Burn - Sound Shore Management 2026 Q2 2.4% Reduce −15.9% 126,994 $79M history
Michael Krensavage - Krensavage Asset Management 2026 Q2 1.4% Add +50.0% 6,000 $4M history
Murphy Pohlad - Murphy Pohlad Asset Management 2026 Q2 0.76% Hold 3,508 $2M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 <0.01% Reduce −4.4% 645 $402K history

6 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
8-K 2.02 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 2, 2026 · 2 forms Filing Doc
4 Period Aug 19, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 10, 2026 · 2 forms Filing Doc
4 Period Jul 2, 2026 Filing Doc
4 Period May 1, 2026 Filing Doc
4 Period Apr 1, 2026 Filing Doc
4 Period Mar 2, 2026 Filing Doc
4 Period Feb 19, 2026 Filing Doc
4 Period Feb 9, 2026 · 2 forms Filing Doc
4 Period Jan 7, 2026 Filing Doc
4 Period Jan 2, 2026 · 11 forms Filing Doc

Updated 12 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $13.12B $14.2B $14.34B
Net income $3.95B $4.41B $4.5B
Net margin * 30.1% 31.1% 31.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $19.48B $18.66B $18.02B
Total non-current assets * $13.6B $19.1B $22.54B
Total assets $33.08B $37.76B $40.56B
Total current liabilities $3.42B $3.94B $4.37B
Total non-current liabilities * $3.68B $4.46B $4.93B
Total equity $25.97B $29.35B $31.26B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $4.59B $4.42B $4.98B
Cash from investing -$3.19B -$2.47B -$0.629B
Cash from financing -$1.79B -$2.2B -$3.72B
Net change in cash -$381.6M -$248.8M $634.7M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders